Prospective, single-center study of the effect on NT-proBNP levels of maintaining sinus rhythm after elective electrical cardioversion for persistent atrial fibrillation in patients with chronic heart failure and ejection fraction < 35% - ECV-HF

Academisch Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新: 2024年4月29日

研究概览

暂无简介。

•1. Diagnosis of chronic heart failure with reduced ejection fraction (<35%) for at least one year, as determined before the episode of AF.
•2. Persistent AF, with a minimal duration of 7 days and a maximal duration of 3 months, and with documented sinus rhythm before the episode of AF.
•3. Successful ECV for persistent AF into sinus rhythm and maintaining sinus rhythm during at least 4 weeks of follow-up.
•4. ICD or CRT-D implant present.
•5. Written informed consent to participate in this study prior to any study procedures

•1. Hospitalization for heart failure in the previous 3 months before inclusion for another reason than for AF,.
•2. Patients undergoing Continue Ambulant Peritoneal Dialysis (CAPD)/ Haemodialysis
•3. Patient with a ST-segment-Elevated Myocardial Infarction (STEMI), CABG, PCI, CRT and/or valvular surgery within 1 month prior to ECV
•4. Patients with planned Coronary Artery Bypass Grafting (CABG), Percutaneous Coronary Intervention (PCI), Cardiac Resynchronization Therapy (CRT) and/or valvular surgery in the month after electrocardioversion.
•5. Documented recurrence of AF of more than 24 hours per week in the last two weeks (or extended period) of follow-up.
•6. Worsening of heart failure requiring hospitalization or visit to the emergency room for other reasons than for AF during the first two weeks, and for any reason during the third to sixth week of study period.
•7. Spontaneous (documented) conversion to sinus rhythm before ECV.
•8. Signed informed consent for any current interventional study.

发起方